Skip to content
10-Q

Quarterly Report

Immuneering Corporation IMRX

0001790340-25-000135

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 39.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.08M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.62M sh
Capex Q3 2025 · Sep 30, 2025 $18.32K
Capex Q3 2025 · Sep 30, 2024 $75.52K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$35.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$40.49M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $227.56M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $36.14M
Stockholders Equity Q3 2025 · Sep 30, 2025 $227.98M
Stockholders Equity Q3 2025 · Jun 30, 2025 $28.94M
Stockholders Equity Q3 2025 · Mar 31, 2025 $41.84M
Stockholders Equity Q3 2025 · Dec 31, 2024 $41.39M
Stockholders Equity Q3 2025 · Sep 30, 2024 $57.72M
Stockholders Equity Q3 2025 · Jun 30, 2024 $66.31M
Stockholders Equity Q3 2025 · Mar 31, 2024 $78.72M
Stockholders Equity Q3 2025 · Dec 31, 2023 $90.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.55M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.5M
Total Liabilities Q3 2025 · Sep 30, 2025 $13.08M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.33M
Current Assets Q3 2025 · Sep 30, 2025 $229.1M
Current Assets Q3 2025 · Dec 31, 2024 $39.59M
Total Assets Q3 2025 · Sep 30, 2025 $241.06M
Total Assets Q3 2025 · Dec 31, 2024 $52.71M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.20
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.45
Eps Basic Q3 2025 · Sep 30, 2025 −$0.38
Eps Basic Q3 2025 · Sep 30, 2025 −$1.20
Eps Basic Q3 2025 · Sep 30, 2024 −$0.49
Eps Basic Q3 2025 · Sep 30, 2024 −$1.45
Sga Expense Q3 2025 · Sep 30, 2025 $4.51M
Sga Expense Q3 2025 · Sep 30, 2025 $12.81M
Sga Expense Q3 2025 · Sep 30, 2024 $4.01M
Sga Expense Q3 2025 · Sep 30, 2024 $12.38M
Rd Expense Q3 2025 · Sep 30, 2025 $10.87M
Rd Expense Q3 2025 · Sep 30, 2025 $32.79M
Rd Expense Q3 2025 · Sep 30, 2024 $11.25M
Rd Expense Q3 2025 · Sep 30, 2024 $33.11M
Net Income Q3 2025 · Sep 30, 2025 −$14.96M
Net Income Q3 2025 · Sep 30, 2025 −$44.44M
Net Income Q3 2025 · Jun 30, 2025 −$14.43M
Net Income Q3 2025 · Mar 31, 2025 −$15.05M
Net Income Q3 2025 · Sep 30, 2024 −$14.6M
Net Income Q3 2025 · Sep 30, 2024 −$42.99M
Net Income Q3 2025 · Jun 30, 2024 −$14.08M
Net Income Q3 2025 · Mar 31, 2024 −$14.31M
Operating Income Q3 2025 · Sep 30, 2025 −$15.38M
Operating Income Q3 2025 · Sep 30, 2025 −$45.62M
Operating Income Q3 2025 · Sep 30, 2024 −$15.27M
Operating Income Q3 2025 · Sep 30, 2024 −$45.51M